bladder disorder
Recently Published Documents


TOTAL DOCUMENTS

10
(FIVE YEARS 4)

H-INDEX

5
(FIVE YEARS 0)

Author(s):  
Julia Mühlbauer ◽  
David Klotz ◽  
Sylvia Büttner ◽  
Raimund Stein ◽  
Nina Younsi

2019 ◽  
pp. 465-498
Author(s):  
Arjun K. Nambiar ◽  
Maike F. Eylert ◽  
Lisette A ‘t Hoen ◽  
Bertil F.M. Blok
Keyword(s):  

2016 ◽  
Vol 311 (2) ◽  
pp. E471-E479 ◽  
Author(s):  
Yi Wang ◽  
Gary G. Deng ◽  
Kelvin P. Davies

There are at present no published studies providing a global overview of changes in bladder metabolism resulting from diabetes. Such studies have the potential to provide mechanistic insight into the development of diabetic bladder disorder (DBD). In the present study, we compared the metabolome of detrusor and urothelial layer in a 1-mo streptozotocin-induced rat model of type 1 diabetes with nondiabetic controls. Our studies revealed that diabetes caused both common and differential changes in the detrusor and urothelial layer's metabolome. Diabetes resulted in similar changes in the levels of previously described diabetic markers in both tissues, such as glucose, lactate, 2-hydroxybutyrate, branched-chain amino acid degradation products, bile acids, and 1,5-anhydroglucitol, as well as markers of oxidative stress. In the detrusor (but not the urothelial layer), diabetes caused activation of the pentose-phosphate and polyol pathways, concomitant with a reduction in the TCA cycle and β-oxidation. Changes in detrusor energy-generating pathways resulted in an accumulation of sorbitol that, through generation of advanced glycation end products, is likely to play a central role in the development of DBD. In the diabetic urothelial layer there was decreased flux of glucose via glycolysis and changes in lipid metabolism, particularly prostaglandin synthesis, which also potentially contributes to detrusor dysfunction.


2016 ◽  
Vol 35 (3) ◽  
pp. 467-472 ◽  
Author(s):  
Yasin Aydogmus ◽  
Salih Uzun ◽  
Fatih C. Gundogan ◽  
Umit Hidir Ulas ◽  
Turgay Ebiloglu ◽  
...  

2016 ◽  
Vol 8 (2) ◽  
pp. 83-90 ◽  
Author(s):  
Joshua A. Cohn ◽  
Elizabeth T. Brown ◽  
W. Stuart Reynolds ◽  
Melissa R. Kaufman ◽  
Douglas F. Milam ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (39) ◽  
pp. 31024-31038 ◽  
Author(s):  
Pradipbhai D. Kalariya ◽  
Mahesh Sharma ◽  
Prabha Garg ◽  
Jagadeshwar Reddy Thota ◽  
Srinivas Ragampeta ◽  
...  

Mirabegron is a novel beta-3 adrenergic receptor agonist in the treatment of overactive bladder disorder.


Sign in / Sign up

Export Citation Format

Share Document